A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Conditions:   Primary Central Nervous System Lymphoma;   Secondary Central Nervous System Lymphoma Intervention:   Drug: GNC-038 Sponsors:   Sichuan Baili Pharmaceutical Co., Ltd.;   SystImmune Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials